(Q34991643)

English

Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

systematic review

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Omar Abdel-Rahman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Z A Elsayed

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

18 September 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

58

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3389-3396

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

https://scigraph.springernature.com/pub.10.1007/s10620-013-2872-x

0 references

Transplantation for hepatocellular carcinoma in younger patients has an equivocal survival advantage as compared with resection

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Evolution of systemic therapy of advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Interim analysis of START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2872-X

21 January 2018

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://pubmed.ncbi.nlm.nih.gov/24046163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus and other risk factors in hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24046163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-013-2872-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24046163%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34991643&oldid=1501727650"